Immunome, Inc.IMNMNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P41
Within normal range
vs 3Y Ago
-1.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -18.37% |
| Q3 2025 | 18.00% |
| Q2 2025 | 6.89% |
| Q1 2025 | -26.14% |
| Q4 2024 | -23.10% |
| Q3 2024 | -46.03% |
| Q2 2024 | -109.46% |
| Q1 2024 | 36.02% |
| Q4 2023 | -102.68% |
| Q3 2023 | -51.98% |
| Q2 2023 | -123.45% |
| Q1 2023 | 461.71% |
| Q4 2022 | 11.73% |
| Q3 2022 | 6.07% |
| Q2 2022 | -26.41% |
| Q1 2022 | 6.30% |
| Q4 2021 | -64.17% |
| Q3 2021 | -10.80% |
| Q2 2021 | -5.83% |
| Q1 2021 | 41.69% |
| Q4 2020 | -139.79% |
| Q3 2020 | -70.81% |
| Q2 2020 | 28.29% |
| Q1 2020 | 19.97% |
| Q4 2019 | -9.33% |
| Q3 2019 | -1.20% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |